期刊文献+

人脐间充质干细胞治疗子痫前期的可行性体外实验 被引量:1

Feasibility test of UC-MSCs transplantation in vitro for the treatment of preeclampsia
下载PDF
导出
摘要 目的探讨人脐间充质干细胞(UC-MSCs)治疗子痫前期的可行性。方法 1)应用DMEM培养人脐静脉内皮细胞(HUVEC),分4组(每组n=30)干预:分别应用含15%健康孕妇血清、含15%子痫前期轻度患者血清、含15%子痫前期重度患者血清(24 h尿蛋白>2~<4 g,简称低蛋白组)及含15%子痫前期重度患者血清(24 h尿蛋白>4 g,简称高蛋白组)在37℃、5%CO2培养箱培养24 h,处理后应用Transwell技术建立内皮细胞通透模型并计算通透系数;2)分别取上述干预后4组细胞的上清液,处理后加入Transwell小室下室,将第5代人脐间充质干细胞以1×105/mL接种到Transwell小室的上室,在37℃、5%CO2培养箱培养24 h后,于200倍镜下随机计数6个无重叠细胞视野的透膜细胞数,取其平均数代表该组细胞的侵袭能力。结果 1)4组的通透系数[Pa(%)]分别为:110.3±2.92、120.7±2.93、141.4±1.81、169.8±2.63(P<0.05)。2)4组透膜细胞数分别为(个):11.00±2.71、24.10±2.92、35.32±6.03、47.00±1.93(P<0.05)。结论子痫前期患者血清对脐静脉内皮细胞有明显损伤,损伤的内皮细胞会对产生趋化作用,而这种趋化作用随着随损伤程度的加重而增强。UC-MSCs移植有可能成为治疗子痫前期的方法之一。 Objective To study the feasibility of UC-MSCs transplantation in vitro for the treatment of preeclampgia.Methods 1 )Human umbilical vein endothelial cells (HUVEC) were planted , then incubated by DMEM' with different contents of sermn,which was divided into 4 groups( n = 30) ,that is 15% serum of healthy pregnant women, 15% serum of patients with mild preeclampsia, 15% serum of patients with severe preeclampsia (whose 24 h urine protein 〉 2 - 〈 4 g), and15% serum of patients with severe preeclampsia (whlose 24 h urine protein 〉 4 g). EndotheliM permeability was meas- ured. 2) Collected the culture solution in a sterile EP of the above 4 groups, then added the solution into the lower chamber of Transwell. The upper chamber of Transwell was filled with the 5th passage of UC-MSCs ( 1 × 105/mL) . After 24 h of in- cubation in 5% CO2 at 37℃ ,the extent of invasion was determined by counting the number of stained cens on the mem- branes in 6 randomly selected, non-overlapping fields at 200 magnification under a light microscope. Results 1 ) The per- meability(Pa% ) of 4 groups were 110.3 ±2.92,120.7 ±2.93,141.4±1.81 and 169.8 ±2. 63(P 〈0.05). 2) The num- ber of stained ceils on the membranes of 4 groups were 11.00 ±2. 71,24. 10 ±2. 92,35.32 ±6. 03 and 47. 00 ±1.93 ( P 〈 0. 05). Conclusion The serum of patients with preeclampsia could induce a significant increase in the EndotheliaI per- meability,the effect on HUVE cells.could increase the chemotactic characteristic of UC-MSCS to vascular endothelial cells incubated. UC-MSCs transplantation could be a kind of treatment for preeclampsitr
出处 《中国输血杂志》 CAS CSCD 北大核心 2013年第6期517-520,共4页 Chinese Journal of Blood Transfusion
关键词 子痫前期 趋化性 人脐静脉内皮细胞 脐带间充质干细胞 preeclampsia chemotaxis human umbilical veins endothelial cell human umbilical cord mesenchymal stem cells
  • 相关文献

参考文献9

  • 1Spaeth E, Klopp A, Dembinski J, et al. Inflammation and tumor mi- cro-environments: defining the migratory itinerary of mesenehymal stemcells. Gene Ther,2008 ( 10), 15 : 730-738. 被引量:1
  • 2苟文丽.妊娠高血压疾病//乐杰.妇产科学.7版,北京:人民卫生出版社,2008:92-99. 被引量:1
  • 3庞花艳,黄引平,刘忠杰,易攀,龚建明,郝华,吴萍,周洁,蔡蕾,黄艳君,叶笃筠,王振焕.脂氧素对脂多糖诱导的脐静脉内皮细胞通透性的影响[J].中华妇产科杂志,2011,46(3):199-204. 被引量:2
  • 4Wang Y, Gu Y, Granger DN, et al. Endothelial junctional protein redistribution and increased monolayer permeability in human um- bilical vein endothelial cells isolated during preeclampsia. Am J Obstet Gynecot ,2002,186 ( 2 ) :214-220. 被引量:1
  • 5Son BR, Marquez-Curtis LA, Kucia M. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated bystro- mal-defived factor-1-CXCR4 and hepatocyte growth factor-c-metax- es and invo UC-MSCSlves matrix metalloproteinases. Stem Cells, 2006,24(5) :1254-1264. 被引量:1
  • 6Li Y,Yu X,Lin S,et al. Insulin-like growth factor 1 enhancea the migratory capacity of mesenchymal stem cel.ls . Biochem Biophys Res Commun',2007,356(2) :780-784. 被引量:1
  • 7Kollet O, Shivtiel S, Chen YQ, et al. HGF, SDF-1, andMMP-9 are involvedin stree-induced human CD34 + stem cell recruitment to the liver. J Clin Invest,2003,112 (6) : 160-169. 被引量:1
  • 8Koizumi K, Sait0h Y, Minami T, et al. Role of CX3CL1/fractalkine in osteoclast dirreretiation and bone resorption J Immunol, 2009, 183 (3) :7825-7831. 被引量:1
  • 9D Haese JG, Demir IE, Ffiess H, et al. Fraactalkine/CX3 CR1 : why a single ehemokine-reeeptor duo bears a major and unique thera- pefitic potential. Expert Opinion on Therapeutic Targets, 2010,14 (2) :207-219. 被引量:1

二级参考文献4

共引文献1

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部